At the LSI 2024 Emerging MedTech Summit, Alpha Sophia’s CEO, Paul-Lukas Hoffschmidt, announced a game-changing update: the Alpha Sophia Enterprise plan now grants full access to all-payer commercial claims data. This enhancement solidifies Alpha Sophia’s position as the most affordable and comprehensive intelligence tool in the market — by a stretch. By democratizing access to invaluable commercial claims data, Alpha Sophia empowers MedTech companies of all sizes to make informed decisions and drive innovation in healthcare.
Biolinq Incorporated, a health tech business using biosensors to improve metabolic health, has raised a $58 million financing round. Alpha Wave Ventures led the round, with participation from Niterra’s corporate venture capital fund jointly operated with Pegasus Tech Ventures. Existing investors that took part in the round include RiverVest Venture Partners, AXA IM Alts, Global Health Investment Corporation, Aphelion Capital, Senvest Management, Features Capital and Taisho Pharmaceutical, according to a press release. Biolinq’s wearable patch, designed to be worn on the upper forearm, has an intuitive device display to let users know when glucose levels are within a target range and when they are elevated beyond a healthy range.
To read more, click here.
EarliTec Diagnostics, a medtech company focused on diagnostics and therapeutics for children with autism, has raised a $21.5 million Series B round. Nexus NeuroTech Ventures and Venture Investors Health Fund led the round. The funds will be used for commercialization and to advance clinical research for an assessment tool to help clinicians in the diagnosis and assessment of autism in children aged 16-to-30 months.
“We are excited to partner with providers across the nation to deliver EarliPoint. We can reduce the time-consuming process of administering and documenting an objective diagnosis and assessment of autistic children, so they can receive effective treatment,” said Tom Ressemann, EarliTec CEO, in a press release. “We believe the field of autism is quickly evolving, and we hope increased access to early diagnostic and assessment tools will allow us to deliver on our mission to ensure families have timely autism diagnosis and therapy when it matters most.”
To read more, click here.
Nourish, a health tech company that connects people to registered dietitians covered by insurance, has raised $35 million in Series A funding. Index Ventures led the round with participation from Maverick Ventures and TCV, according to a press release. Existing investors Y Combinator, Thrive Capital and BoxGroup and several prominent angel investors including professional soccer player Alex Morgan and founders from Oscar, Olipop, and Notion also took part in the round. The funds will help Nourish accelerate development of its digital platform for patients and providers, expand its network of registered dietitians, and deepen its strategic partnerships with insurance companies.
To read more, click here.
